Literature DB >> 31197690

Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3-5 cm): a Propensity Score Matching Cohort Study.

Qing-Wang Ye1,2, Shu-Jie Pang1, Ning Yang1, Hai-Bin Zhang1, Yong Fu1, Bin Lin3, Guang-Shun Yang4.   

Abstract

BACKGROUND: We aim to investigate the safety and efficacy of radiofrequency ablation in the treatment of solitary hepatocellular carcinoma (3-5 cm) in comparison with surgical resection.
METHODS: Included in this study were 388 patients with primary and solitary hepatocellular carcinoma, of whom 196 patients underwent surgical resection and the other 192 patients received radiofrequency ablation. Clinicopathological characteristics, prognosis, post-treatment complications, hospital stay, and financial expenditures between the two groups were compared retrospectively.
RESULTS: The result of propensity score matching and subgroup analysis showed that the 1-, 3-, and 5-year overall survival and disease-free survival were comparable in patients with tumors of 3-4 cm in diameter between surgical resection and radiofrequency ablation groups. However, when the tumor size exceeded 4 cm in diameter, surgical resection exhibited a superior long-term prognosis compared with radiofrequency ablation. Nevertheless, hepatectomy was associated with high occurrences of postoperative complications, long hospital stay, and high hospitalization cost as compared with radiofrequency ablation. Further analysis of the relationship between tumor size and pathological features of hepatocellular carcinoma showed that tumors larger than 4 cm were positively correlated with a high rate of microvascular invasion and satellite nodule formation.
CONCLUSION: For solitary hepatocellular carcinoma of 3-4 cm in diameter, radiofrequency ablation could achieve a comparable prognosis with a low incidence of post-treatment complications and low hospitalization costs, while surgical resection is recommended for solitary hepatocellular carcinoma tumors of 4-5 cm in diameter when long-term prognosis is considered.

Entities:  

Keywords:  Hepatectomy; Hepatocellular carcinoma; Prognosis; Radiofrequency ablation

Mesh:

Year:  2019        PMID: 31197690     DOI: 10.1007/s11605-019-04229-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study.

Authors:  Wei-Xing Guo; Bo Zhai; Eric C H Lai; Nan Li; Jie Shi; Wan-Yee Lau; Meng-Chao Wu; Shu-Qun Cheng
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; A-Hon Kwon
Journal:  J Surg Oncol       Date:  2010-10-01       Impact factor: 3.454

Review 3.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

4.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

5.  Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.

Authors:  Alessandro Cucchetti; Fabio Piscaglia; Antonia D'Errico Grigioni; Matteo Ravaioli; Matteo Cescon; Matteo Zanello; Gian Luca Grazi; Rita Golfieri; Walter Franco Grigioni; Antonio Daniele Pinna
Journal:  J Hepatol       Date:  2010-03-24       Impact factor: 25.083

6.  Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

Authors:  Patrick P McHugh; Jeffrey Gilbert; Santiago Vera; Alvaro Koch; Dinesh Ranjan; Roberto Gedaly
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

7.  Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

Authors:  L Lupo; P Panzera; G Giannelli; M Memeo; A Gentile; V Memeo
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Authors:  Shuji Sumie; Ryoko Kuromatsu; Koji Okuda; Eiji Ando; Akio Takata; Nobuyoshi Fukushima; Yasutomo Watanabe; Masamichi Kojiro; Michio Sata
Journal:  Ann Surg Oncol       Date:  2008-03-07       Impact factor: 5.344

9.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.

Authors:  Sasan Roayaie; Iris N Blume; Swan N Thung; Maria Guido; Maria-Isabel Fiel; Spiros Hiotis; Daniel M Labow; Josep M Llovet; Myron E Schwartz
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

Review 10.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

View more
  1 in total

1.  Comparison of surgical resection and radiofrequency ablation for stages I and II elderly hepatocellular carcinoma patients (≥ 65 years): A SEER population-based propensity score matching's study.

Authors:  Qingqing Xie; Yongwen Yang; Bin Qu; Ping Xiao; Faqing Tang; Haoming Shen
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.